3-(2,2,2-trimethylhydrazine)propionate has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borković-Mitić, S; Ivanović, A; Jasnić, N; Pavlović, S; Sopta, J; Stojković, M; Todorović, Z; Tosti, T; Đorđević, J; Đurašević, S; Đurović, S | 1 |
| Beier, K; Kaufmann, P; Krähenbühl, S; März, W; Scharnagl, H; Spaniol, M; Török, M; Wüthrich, J | 1 |
2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Liver Dysfunction
| Article | Year |
|---|---|
The effects of meldonium on the acute ischemia/reperfusion liver injury in rats.
Topics: Acute Disease; Animals; Gene Expression Regulation; Inflammation; Liver; Liver Diseases; Male; Methylhydrazines; Rats; Rats, Wistar; Reperfusion Injury | 2021 |
Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate.
Topics: Acyl-CoA Oxidase; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Electron Transport; Ketone Bodies; Lipids; Lipoproteins; Liver; Liver Diseases; Methylhydrazines; Mitochondria, Liver; Oxidation-Reduction; Oxidoreductases; Palmitates; Rats; Rats, Sprague-Dawley | 2003 |